EPA Influenced to Delay Glyphosate Cancer Review

Biotech companies, including Monsanto, have all influenced the EPA in postponing these important and necessary meetings saying the speakers will be too biased.

665
SOURCENationofChange

Oct. 18-21 was supposed to be a four-day public meeting event, held by the EPA, to discuss if glyphosate is safe. The EPA Scientific Advisory Panel decided to postpone the meetings after heavy lobbying by the agrichemical industry.

Biotech companies, including Monsanto, have all influenced the EPA in postponing these important and necessary meetings, saying the speakers will be too biased.

“EPA should replace Dr. Infante with an epidemiologist without such patent bias,” CropLife, which represents the interests of Monsanto and other agribusinesses, told the EPA.

FALL FUNDRAISER

If you liked this article, please donate $5 to keep NationofChange online through November.

COMMENTS